PortfoliosLab logoPortfoliosLab logo
INSP vs. RMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INSP vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INSP achieves a -55.17% return, which is significantly lower than RMD's -21.35% return.


INSP

1D
-2.96%
1M
-5.68%
YTD
-55.17%
6M
-57.78%
1Y
-68.41%
3Y*
-49.18%
5Y*
-26.94%
10Y*

RMD

1D
-0.10%
1M
-9.42%
YTD
-21.35%
6M
-23.20%
1Y
-24.99%
3Y*
-3.40%
5Y*
-4.15%
10Y*
13.30%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INSP vs. RMD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
INSP
Inspire Medical Systems, Inc.
-55.17%-50.25%-8.87%-19.24%9.48%22.31%153.46%75.64%72.52%
RMD
ResMed Inc.
-21.35%6.26%34.18%-16.55%-19.47%23.41%38.33%37.85%20.10%

Correlation

The correlation between INSP and RMD is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (All Time)
Calculated using the full available price history since May 3, 2018

0.41

The correlation between INSP and RMD shifts across timeframes, from 0.32 (1 year) to 0.44 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

INSP:

$4.48

RMD:

$13.78

PE Ratio

INSP:

9.23

RMD:

13.68

PEG Ratio

INSP:

0.05

RMD:

0.42

PS Ratio

INSP:

1.32

RMD:

3.75

Total Revenue (TTM)

INSP:

$915.25M

RMD:

$5.54B

Gross Profit (TTM)

INSP:

$785.06M

RMD:

$3.42B

EBITDA (TTM)

INSP:

$67.14M

RMD:

$2.10B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INSP vs. RMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSP
INSP Risk / Return Rank: 66
Overall Rank
INSP Sharpe Ratio Rank: 77
Sharpe Ratio Rank
INSP Sortino Ratio Rank: 66
Sortino Ratio Rank
INSP Omega Ratio Rank: 55
Omega Ratio Rank
INSP Calmar Ratio Rank: 44
Calmar Ratio Rank
INSP Martin Ratio Rank: 77
Martin Ratio Rank

RMD
RMD Risk / Return Rank: 99
Overall Rank
RMD Sharpe Ratio Rank: 44
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 77
Sortino Ratio Rank
RMD Omega Ratio Rank: 88
Omega Ratio Rank
RMD Calmar Ratio Rank: 1717
Calmar Ratio Rank
RMD Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSP vs. RMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INSPRMDDifference
Sharpe ratioReturn per unit of total volatility

+0.11

Sortino ratioReturn per unit of downside risk

-0.15

Omega ratioGain probability vs. loss probability

0.79

0.84

-0.05

Calmar ratioReturn relative to maximum drawdown

-0.95

-0.67

-0.28

Martin ratioReturn relative to average drawdown

-1.45

-1.45

+0.01

INSP vs. RMD - Sharpe Ratio Comparison

The current INSP Sharpe Ratio is -0.92, which is comparable to the RMD Sharpe Ratio of -1.03. The chart below compares the historical Sharpe Ratios of INSP and RMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INSP vs. RMD - Drawdown Comparison

The maximum INSP drawdown since its inception was -87.72%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for INSP and RMD.


Loading charts...

Drawdown Indicators


INSPRMDDifference

Max Drawdown

Largest peak-to-trough decline

-87.72%

-61.61%

-26.11%

Max Drawdown (1Y)

Largest decline over 1 year

-72.19%

-37.28%

-34.91%

Max Drawdown (3Y)

Largest decline over 3 years

-87.72%

-40.09%

-47.63%

Max Drawdown (5Y)

Largest decline over 5 years

-87.72%

-53.99%

-33.73%

Max Drawdown (10Y)

Largest decline over 10 years

-53.99%

Current Drawdown

Current decline from peak

-87.32%

-35.35%

-51.97%

Average Drawdown

Average peak-to-trough decline

-27.91%

-16.01%

-11.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.31%

17.21%

+30.10%

Volatility

INSP vs. RMD - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD) have volatilities of 10.74% and 10.27%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INSPRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.74%

10.27%

+0.47%

Volatility (6M)

Calculated over the trailing 6-month period

46.88%

19.64%

+27.24%

Volatility (1Y)

Calculated over the trailing 1-year period

74.93%

24.42%

+50.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.32%

31.00%

+29.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.48%

31.55%

+28.93%

Dividends

INSP vs. RMD - Dividend Comparison

INSP has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 1.27%.


PositionTTM20252024202320222021202020192018201720162015
INSP
Inspire Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RMD
ResMed Inc.
1.27%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Financials

INSP vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
204.58M
1.43B
(INSP) Total Revenue
(RMD) Total Revenue
Values in USD except per share items

INSP vs. RMD - Profitability Comparison

The chart below illustrates the profitability comparison between Inspire Medical Systems, Inc. and ResMed Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%20222023202420252026
86.5%
62.3%
Portfolio components
INSP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a gross profit of 176.91M and revenue of 204.58M. Therefore, the gross margin over that period was 86.5%.

RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.

INSP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported an operating income of -1.12M and revenue of 204.58M, resulting in an operating margin of -0.6%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.

INSP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Inspire Medical Systems, Inc. reported a net income of -11.29M and revenue of 204.58M, resulting in a net margin of -5.5%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.


Frequently Asked Questions


INSP and RMD have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSP has higher volatility (10.74%) compared to RMD (10.27%). In terms of maximum drawdown, INSP dropped -87.72% vs RMD's -61.61%.

INSP currently has the higher Sharpe Ratio (-0.92 vs -1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INSP and RMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer